Navigation Links
ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development
Date:7/28/2014

LOS ANGELES, SINGAPORE, and TOKYO, July 28, 2014 /PRNewswire/ -- ImaginAb, Inc. today announced today announced that it has appointed Roger Crystal, MD as Vice President of Business Development. Dr. Crystal most recently served in the Global Business Development Product Acquisition & Licensing team at G.E. Life Sciences.

"Roger's experience in developing business strategy and partnerships in the precision medicine space will be extremely valuable as we continue to partner with biotechnology and pharmaceutical companies across the spectrum to extend the reach of ImaginAb's capabilities," said Dr. Christian Behrenbruch, co-founder and CEO of ImaginAb. "We are very pleased to welcome Roger to Los Angeles and look forward to his contributions as a member of the ImaginAb executive team."

Prior to joining ImaginAb, Dr. Crystal served on the Global Business Development Product Acquisition & Licensing team at G.E. Life Sciences where he was responsible for evaluating in vivo and in vitro molecular and IT technologies for acquisitions, licensing or partnering deals.  In this capacity he also managed pharmaceutical company engagements, out-licensing deals and commercialization partnerships for late stage molecular imaging agents including molecular imaging technologies. Dr. Crystal also has prior management consulting and corporate M&A experience from AT Kearney and Goldman Sachs.

"ImaginAb's proprietary antibody fragment technology has the potential to transform the way patients are staged and managed in cancer and immunology indications," commented Dr. Crystal. "I am enthusiastic to be joining ImaginAb, particularly at a time when the application of our products has the potential to further advance the tremendous progress being made in the immuno-oncology field."

Dr. Crystal holds degrees in Medicine and Physiology from the University of Birmingham and an MBA from the London Business School.  Dr. Crystal began his career as a surgeon at University College Hospital London and is a member of the Royal College of Surgeons of England specializing in otolaryngology, most recently at St Mary's Hospital (Imperial College), London.

About ImaginAb
ImaginAb is redefining therapeutic management by harnessing the power of antibody technology for in vivo imaging.  The company's proprietary antibody fragment platform yields actionable molecular information to guide treatment decisions in cancer and immunology. ImaginAb also collaborates with select biopharmaceutical partners to design imaging agents as companion diagnostics for therapeutic antibodies. ImaginAb's technology is positioned to deliver on the promise of precision medicine by improving patient outcomes and reducing the cost of healthcare.

For more information, visit www.imaginab.com.


'/>"/>
SOURCE ImaginAb, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ImaginAb and MacroGenics Collaborate to Develop In Vivo Imaging Agents for Autoimmune Diseases, Cancer
2. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
3. ImaginAb and Singapore Radiopharmaceuticals Sign Master Service Agreement
4. Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer
5. Pharmavite Appoints Timothy Toll Chief Customer Officer
6. Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer
7. BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors
8. PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board
9. Nonin Medical Appoints Ash Keswani Vice President of Marketing
10. InspireMD Appoints Dr. James Barry as Chief Operating Officer
11. Xencor Appoints Kurt Gustafson to Board of Directors; Promotes John Desjarlais to Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health ... it will be presenting at the 7th annual LD Micro Invitational ... Raphael , CEO, of DarioHealth will be giving the presentation and ... June 6th & 7th, 2017 at the Luxe Sunset Bel Air ... space. About LD Micro LD ...
(Date:5/30/2017)... 2017 Therapix Biosciences Ltd. (Nasdaq: TRPX), ... the development of cannabinoid-based drugs, today announced that ... at three upcoming scientific and investor conferences in ... Invitational: ...                     Wednesday, June ...
(Date:5/26/2017)... -- Endo International plc (NASDAQ: ENDP ) announced today ... the Company in a fireside chat at Goldman Sachs, 38 ... 2017 at 10:40 a.m. PT / 1:40 p.m. ET. The ... Rancho Palos Verdes, CA. A live ... on the Company,s website at http://www.endo.com/investors/overview . Participants should ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. Ran Y. ... has recently begun offering three new minimally invasive procedures to patients who want ... reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, and platelet ...
(Date:6/23/2017)... Washington, D.C. (PRWEB) , ... June 23, 2017 ... ... temperature during cooking is essential, and two new videos highlight the importance of ... Extension Specialist Christine Bruhn, Ph.D., who has done extensive research on consumer food ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance Agency ... the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more people ... the Biggert-Waters Act was enacted to reflect the actual risk in flood zone ...
(Date:6/23/2017)... Gilmer, TX (PRWEB) , ... June 23, 2017 , ... ... consultations to residential and business clients throughout eastern Texas, is announcing the launch of ... , Recent breast cancer statistics in the United States reveal that an estimated ...
(Date:6/22/2017)... IN (PRWEB) , ... June 22, 2017 , ... ... benefits advisory organization, is pleased to welcome Whipple & Company as its newest ... the clear purpose of balancing their clients’ risk while tailoring optimized benefit packages ...
Breaking Medicine News(10 mins):